14-day Premium Trial Subscription Try For FreeTry Free
NYSE:MSTX
Delisted

Mast Therapeutics, Inc Fund Price (Quote)

New York Stock Exchange
Open Broker Account
$0.130
+0 (+0%)
At Close: Jan 16, 2018
Forecast Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 16th Jan 2018 MSTX stock ended at $0.130. During the day the stock fluctuated 0% from a day low at $0.130 to a day high of $0.130.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Mast Therapeutics, Inc prices

Date Open High Low Close Volume
Aug 18, 2016 $0.390 $0.420 $0.390 $0.410 2 048 400
Aug 17, 2016 $0.410 $0.410 $0.390 $0.400 1 620 200
Aug 16, 2016 $0.420 $0.430 $0.400 $0.420 2 207 400
Aug 15, 2016 $0.400 $0.430 $0.390 $0.420 4 262 600
Aug 12, 2016 $0.360 $0.390 $0.350 $0.390 4 469 900
Aug 11, 2016 $0.350 $0.360 $0.340 $0.350 1 294 000
Aug 10, 2016 $0.350 $0.380 $0.340 $0.350 1 287 200
Aug 09, 2016 $0.360 $0.360 $0.340 $0.350 1 395 300
Aug 08, 2016 $0.330 $0.350 $0.330 $0.350 1 629 000
Aug 05, 2016 $0.320 $0.350 $0.260 $0.340 2 056 900
Aug 04, 2016 $0.350 $0.360 $0.340 $0.340 1 648 900
Aug 03, 2016 $0.360 $0.360 $0.340 $0.350 1 762 700
Aug 02, 2016 $0.360 $0.360 $0.340 $0.350 1 972 300
Aug 01, 2016 $0.370 $0.380 $0.350 $0.360 3 161 600
Jul 29, 2016 $0.360 $0.370 $0.340 $0.360 2 858 400
Jul 28, 2016 $0.370 $0.370 $0.350 $0.360 1 957 700
Jul 27, 2016 $0.350 $0.370 $0.330 $0.370 4 128 700
Jul 26, 2016 $0.340 $0.370 $0.220 $0.350 16 976 500
Jul 25, 2016 $0.450 $0.450 $0.400 $0.420 4 672 600
Jul 22, 2016 $0.430 $0.440 $0.410 $0.440 2 895 400
Jul 21, 2016 $0.440 $0.440 $0.400 $0.410 3 275 600
Jul 20, 2016 $0.440 $0.440 $0.420 $0.430 1 894 500
Jul 19, 2016 $0.460 $0.460 $0.430 $0.430 2 094 100
Jul 18, 2016 $0.450 $0.460 $0.440 $0.440 2 405 500
Jul 15, 2016 $0.450 $0.450 $0.430 $0.430 2 613 900
Click to get the best stock tips daily for free!

About Mast Therapeutics, Inc

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of hear... MSTX Profile

Golden Star

Ticker Date Change Price
VCSH May 03 0.0130% $76.93
BNDX May 03 0.349% $48.68
BBCA May 03 1.26% $65.44
ISTB May 03 0.0425% $47.11
ADTH May 03 5.56% $3.24
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT